Opin vísindi

Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

Skoða venjulega færslu

dc.contributor Háskóli Íslands
dc.contributor University of Iceland
dc.contributor.author Allen, Richard J.
dc.contributor.author Guillen-Guio, Beatriz
dc.contributor.author Oldham, Justin M.
dc.contributor.author Ma, Shwu-Fan
dc.contributor.author Dressen, Amy
dc.contributor.author Paynton, Megan L.
dc.contributor.author Kraven, Luke M.
dc.contributor.author Obeidat, Ma'en
dc.contributor.author Li, Xuan
dc.contributor.author Ng, Michael
dc.contributor.author Braybrooke, Rebecca
dc.contributor.author Molina-Molina, Maria
dc.contributor.author Hobbs, Brian D.
dc.contributor.author Putman, Rachel K.
dc.contributor.author Sakornsakolpat, Phuwanat
dc.contributor.author Booth, Helen L.
dc.contributor.author Fahy, William A.
dc.contributor.author Hart, Simon P.
dc.contributor.author Hill, Mike R.
dc.contributor.author Hirani, Nik
dc.contributor.author Hubbard, Richard B.
dc.contributor.author McAnulty, Robin J.
dc.contributor.author Millar, Ann B.
dc.contributor.author Navaratnam, Vidyia
dc.contributor.author Oballa, Eunice
dc.contributor.author Parfrey, Helen
dc.contributor.author Saini, Gauri
dc.contributor.author Whyte, Moira K. B.
dc.contributor.author Zhang, Yingze
dc.contributor.author Kaminski, Naftali
dc.contributor.author Adegunsoye, Ayodeji
dc.contributor.author Strek, Mary E.
dc.contributor.author Neighbors, Margaret
dc.contributor.author Sheng, Xuting R.
dc.contributor.author Guðmundsson, Gunnar
dc.contributor.author Gudnason, Vilmundur
dc.contributor.author Hatabu, Hiroto
dc.contributor.author Lederer, David J.
dc.contributor.author Manichaikul, Ani
dc.contributor.author Newell, John D.
dc.contributor.author O’Connor, George T.
dc.contributor.author Ortega, Victor E.
dc.contributor.author Xu, Hanfei
dc.contributor.author Fingerlin, Tasha E.
dc.contributor.author Bossé, Yohan
dc.contributor.author Hao, Ke
dc.contributor.author Joubert, Philippe
dc.contributor.author Nickle, David C.
dc.contributor.author Sin, Don D.
dc.contributor.author Timens, Wim
dc.contributor.author Furniss, Dominic
dc.contributor.author Morris, Andrew P.
dc.contributor.author Zondervan, Krina T.
dc.contributor.author Hall, Ian P.
dc.contributor.author Sayers, Ian
dc.contributor.author Tobin, Martin D.
dc.contributor.author Maher, Toby M.
dc.contributor.author Cho, Michael H.
dc.contributor.author Hunninghake, Gary M.
dc.contributor.author Schwartz, David A.
dc.contributor.author Yaspan, Brian L.
dc.contributor.author Molyneaux, Philip L.
dc.contributor.author Flores, Carlos
dc.contributor.author Noth, Imre
dc.contributor.author Jenkins, R. Gisli
dc.contributor.author Wain, Louise V.
dc.date.accessioned 2021-01-28T11:33:34Z
dc.date.available 2021-01-28T11:33:34Z
dc.date.issued 2020-03-01
dc.identifier.citation Allen, R. J., et al. (2019). "Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis." American Journal of Respiratory and Critical Care Medicine 201(5): 564-574.
dc.identifier.issn 1073-449X
dc.identifier.issn 1535-4970 (eISSN)
dc.identifier.uri https://hdl.handle.net/20.500.11815/2428
dc.description Publisher's version (útgefin grein)
dc.description.abstract Rationale: Idiopathic pulmonary fibrosis (IPF) is a complex lung disease characterized by scarring of the lung that is believed to result from an atypical response to injury of the epithelium. Genome-wide association studies have reported signals of association implicating multiple pathways including host defense, telomere maintenance, signaling, and cell-cell adhesion. Objectives: To improve our understanding of factors that increase IPF susceptibility by identifying previously unreported genetic associations. Methods: We conducted genome-wide analyses across three independent studies and meta-analyzed these results to generate the largest genome-wide association study of IPF to date (2,668 IPF cases and 8,591 controls). We performed replication in two independent studies (1,456 IPF cases and 11,874 controls) and functional analyses (including statistical fine-mapping, investigations into gene expression, and testing for enrichment of IPF susceptibility signals in regulatory regions) to determine putatively causal genes. Polygenic risk scores were used to assess the collective effect of variants not reported as associated with IPF. Measurements and Main Results: We identified and replicated threenewgenome-wide significant (P<5×10-8) signals of association with IPF susceptibility (associated with altered gene expression of KIF15, MAD1L1, and DEPTOR) and confirmed associations at 11 previously reported loci. Polygenic risk score analyses showed that the combined effect of many thousands of as yet unreported IPF susceptibility variants contribute to IPF susceptibility. Conclusions: The observation that decreased DEPTOR expression associates with increased susceptibility to IPF supports recent studies demonstrating the importance of mTOR signaling in lung fibrosis. New signals of association implicating KIF15 and MAD1L1 suggest a possible role of mitotic spindle-assembly genes in IPF susceptibility.
dc.description.sponsorship R.J.A. is an Action for Pulmonary Fibrosis Research Fellow. L.V.W. holds a GSK/British Lung Foundation Chair in Respiratory Research. R.G.J. is supported by a National Institute for Health Research (NIHR) Research Professorship (NIHR reference RP-2017-08-ST2-014). I.N. is supported by the NHLBI (R01HL130796). B.G.-G. is funded by Agencia Canaria de Investigación, Innovación y Sociedad de la Información (TESIS2015010057) cofunded by European Social Fund. J.M.O. is supported by the NHLBI (K23HL138190). C.F. is supported by the Spanish Ministry of Science, Innovation and Universities (grant RTC-2017-6471-1; Ministerio de Ciencia e Innovacion/Agencia Estatal de Investigación/Fondo Europeo de Desarrollo Regional, Unión Europea) cofinanced by the European Regional Development Funds “A way of making Europe” from the European Union and by agreement OA17/008 with Instituto Tecnológico y de Energías Renovables to strengthen scientific and technological education, training, research, development and innovation in Genomics, Personalized Medicine and Biotechnology. The Spain Biobank array genotyping service was performed at CEGEN-PRB3-ISCIII, which is supported by PT17/0019, of the PE I+D+i 2013–2016, funded by Instituto de Salud Carlos III, and cofinanced by the European Regional Development Funds. P.L.M. is an Action for Pulmonary Fibrosis Research Fellow. M.O. is a fellow of the Parker B. Francis Foundation and a Scholar of the Michael Smith Foundation for Health Research. B.D.H. is supported by NIH K08 HL136928, Parker B. Francis Research Opportunity Award. M.H.C. and G.M.H. are supported by NHLBI grants R01HL113264 (M.H.C.), R01HL137927 (M.H.C.), R01HL135142 (M.H.C. and G.M.H.), R01111024 (G.M.H.), and R01130974 (G.M.H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funding body has no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. T.M.M. is supported by an NIHR Clinician Scientist Fellowship (NIHR Ref: CS-2013-13-017) and a British Lung Foundation Chair in Respiratory Research (C17-3). M.D.T. is supported by a Wellcome Trust Investigator Award (WT202849/Z/16/Z). The research was partially supported by the NIHR Leicester Biomedical Research Centre; the views expressed are those of the author(s) and not necessarily those of the National Health Service (NHS), the NIHR, or the Department of Health. I.P.H. was partially supported by the NIHR Nottingham Biomedical Research Centre; the views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. I.S. is supported by Medical Research Council (G1000861) and Asthma UK (AUK-PG-2013-188). D.F. was supported by an Intermediate Fellowship from the Wellcome Trust (097152/Z/11/Z). This work was partially supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. V.N. is funded by an NIHR Clinical Lectureship. G.G. is supported by project grant 141513-051 from the Icelandic Research Fund and Landspitali Scientific Fund A-2016-023, A-2017-029, and A-2018-025. D.J.L. and A.M. are supported by Multi-Ethnic Study of Atherosclerosis (MESA) and the MESA SNP Health Association Resource (SHARe) project are conducted and supported by the NHLBI in collaboration with MESA investigators. Support for MESA is provided by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, UL1-TR-001881, and DK063491. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. Genotyping was performed at Affymetrix (Santa Clara, California) and the Broad Institute of Harvard and Massachusetts Institute of Technology (Boston, Massachusetts) using the Affymetrix Genome-Wide Human SNP Array 6.0. This work was supported by NIH grants R01 HL131565 (A.M.), R01 HL103676 (D.J.L.), and R01 HL137234 (D.J.L.).
dc.format.extent 564-574
dc.language.iso en
dc.publisher American Thoracic Society
dc.relation.ispartofseries American Journal of Respiratory and Critical Care Medicine;201(5)
dc.rights info:eu-repo/semantics/openAccess
dc.subject DEPTOR
dc.subject Epidemiology
dc.subject Genetics
dc.subject KIF15
dc.subject MAD1L1
dc.subject Erfðafræði
dc.subject Genarannsóknir
dc.subject Lungnasjúkdómar
dc.title Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
dc.type info:eu-repo/semantics/article
dcterms.license This article is open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/ licenses/by/4.0/).
dc.description.version Peer Reviewed
dc.identifier.journal American Journal of Respiratory and Critical Care Medicine
dc.identifier.doi 10.1164/rccm.201905-1017OC
dc.relation.url https://www.atsjournals.org/doi/pdf/10.1164/rccm.201905-1017OC
dc.contributor.department Læknadeild (HÍ)
dc.contributor.department Faculty of Medicine (UI)
dc.contributor.school Heilbrigðisvísindasvið (HÍ)
dc.contributor.school School of Health Sciences (UI)


Skrár

Þetta verk birtist í eftirfarandi safni/söfnum:

Skoða venjulega færslu